Evidence map›Paper›PMID 30376347›Full record

ArticleNano letters2018

Improving the Enzymatic Stability and the Pharmacokinetics of Oligonucleotides via DNA-Backboned Bottlebrush Polymers.

Fei Jia, Dali Wang, Xueguang Lu, Xuyu Tan, Yuyan Wang, Hao Lu, Ke Zhang

Abstract read
In one paragraph

Article in Nano letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Functional DNA-Polymer Conjugates.Chemical reviews · 2021
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fei JiaDepartment of Chemistry and Chemical Biology , Northeastern University , Boston , Massachusetts 02115 , United States.
Dali WangDepartment of Chemistry and Chemical Biology , Northeastern University , Boston , Massachusetts 02115 , United States.
Xueguang LuDepartment of Chemistry and Chemical Biology , Northeastern University , Boston , Massachusetts 02115 , United States.
Xuyu TanDepartment of Chemistry and Chemical Biology , Northeastern University , Boston , Massachusetts 02115 , United States.
Yuyan WangDepartment of Chemistry and Chemical Biology , Northeastern University , Boston , Massachusetts 02115 , United States.
Hao LuDepartment of Chemistry and Chemical Biology , Northeastern University , Boston , Massachusetts 02115 , United States.
Ke ZhangDepartment of Chemistry and Chemical Biology , Northeastern University , Boston , Massachusetts 02115 , United States.ORCID 0000-0002-8142-6702

Funding

Making Oligonucleotides Better Biopharmaceuticals by Steric ProtectionR01GM121612 · NIGMS · NORTHEASTERN UNIVERSITY · PI Ke Zhang · 2017 to 2026
$3.7M
NIGMS NIH HHS R01 GM121612
6 · The paper itself

Abstract

Herein, we design and synthesize site-specifically PEGylated oligonucleotide hairpins and demonstrate that their ability to undergo hybridization chain reaction is nearly unaffected by the PEGylation. The resulting DNA-backboned bottlebrush polymers with PEG side chains exhibit increased resistance against nucleolytic degradation, enhanced thermal stabilities, and elevated blood retention times in vivo, which collectively pave the way for more therapeutically focused DNA nanostructure designs.

Indexed as

OligonucleotidesPolyethylene GlycolsOligonucleotidesPolyethylene GlycolsBottlebrush polymerDNA nanotechnologyhybridization chain reactionoligonucleotidePEGylation

Identifiers

PMID30376347
PMCPMC6571500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.